Tirofiban for the treatment of ischaemic stroke.

about

The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.

P2860

Q46619994-19589A89-499B-4148-8D75-885EEB0B52F3

P2860

Tirofiban for the treatment of ischaemic stroke.

Item

http://www.wikidata.org/entity/Q36349613

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Tirofiban for the treatment of ischaemic stroke.

@ast

Tirofiban for the treatment of ischaemic stroke.

@en

type

Item

label

Tirofiban for the treatment of ischaemic stroke.

@ast

Tirofiban for the treatment of ischaemic stroke.

@en

prefLabel

Tirofiban for the treatment of ischaemic stroke.

@ast

Tirofiban for the treatment of ischaemic stroke.

@en

P1476

Tirofiban for the treatment of ischaemic stroke.

@en

P2093

Michael Daffertshofer

http://www.w3.org/2001/XMLSchema#string

Michael G Hennerici

http://www.w3.org/2001/XMLSchema#string

Simone C Bukow

http://www.w3.org/2001/XMLSchema#string

P2860

Ongoing and planned trials of antiplatelet therapy in the acute and long-term management of patients with ischaemic brain syndromes: setting a new standard of care

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial.

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.

Tirofiban. A review of its use in acute coronary syndromes.

Clinical pharmacokinetics of tirofiban, a nonpeptide glycoprotein IIb/IIIa receptor antagonist: comparison with the monoclonal antibody abciximab.

Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT.

P304

73-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.7.1.73

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16370924

http://www.w3.org/2001/XMLSchema#string

Tirofiban for the treatment of ischaemic stroke.

about

P2860

P2860

Tirofiban for the treatment of ischaemic stroke.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698